Volume : 09, Issue : 06, June – 2022

Title:

08.PHYTOCHEMICAL SCREENING AND EVALUATION OF ANTIULCER ACTIVITY OF ETHANOLIC EXTRACT BETA VULGARIS L. LEAVES

Authors :

Himanshi Modi*, Nupur Agarwal, Sheikh Aariz, Rajat Singh Rathore, Vivek Kumar Sinha, Dr. Harshita Jain

Abstract :

Gastroesophageal reflux disease, gastritis, peptic ulcer, duodenal ulcer, and other peptic illnesses are frequent in today’s lifestyle. This could be the result of a hectic lifestyle or an unbalanced diet. The pathophysiology underlying these illnesses could be a mismatch between offensive and defensive mechanisms, either due to excessive acid and pepsin secretion or a decreased ability of the gastro-duodenal mucosal barrier to guard against acid-pepsin secretion from the stomach. Non-steroidal anti-inflammatory drugs (NSAIDs) are a type of therapy that has been shown to be beneficial in treating a variety of ailments. Some people take NSAIDs on a daily basis to keep themselves healthy. NSAIDs, on the other hand, can cause a wide range of serious adverse effects. Studies have shown that edible natural ingredients exhibit preventive benefit of gastric ulcer. As a result, the purpose of this study was to assess the antiulcer activity of an ethanolic extract of Beta vulgaris leaves in rats. The well-known test technique in the literature was used to determine the qualitative analysis of several phytochemical elements. The anti-ulcer efficacy of ethanolic extract was tested in vivo. The pH of stomach fluid, ulcer index, and percent inhibition of ulcer index were used as outcome measures, depending on the model. Because of one or more of the secondary metabolites included in Beta vulgaris extract, the results of this investigation indicated that it possesses anti-ulcer pharmacologic efficacy. As a result, this research backs up its anti-ulcer use in Indian folk medicine. More research is needed into isolating particular phytochemicals and understanding mechanisms of action.
Keywords:Beta vulgaris, Phytochemical constituents, Antiulcer, Non-steroidal anti-inflammatory drugs

Cite This Article:

Please cite this article in pressHimanshi Modiet al,Phytochemical screening and evaluation of antiulcer activity of ethanolic extract beta vulgaris l. Leaves .,Indo Am. J. P. Sci, 2022; 09(6).,

Number of Downloads : 10

References:

1. F. K. L. Chan and D. Y. Graham, Review article: prevention of non-steroidal anti-inflammatory drug gastrointestinal complications-review and recommendations based on risk assessment, Alimentary Pharmacology and Therapeutics, vol. 19, no. 10, pp. 1051–1061, 2004.
2. B. Debjit, C. Chiranjib, K. K. Tripathi, Pankaj, and K. P. Sampath Kumar, Recent trends of treatment and medication peptic ulcerative disorder, International Journal of Pharm Tech Research, 2 (1), 970–980, 2010.
3. N. S. Vyawahare, V. V. Deshmukh, M. R. Godkari, and V. G. Kagathara, “Plants with anti-ulcer activity,” Pharmacognosy Review, vol. 3, pp. 108–115, 2009.
4. F. P. Brooks, “The pathophysiology of peptic ulcer disease,” Digestive Diseases and Sciences, vol. 30, supplement 11, pp. 15S– 29S, 1985.
5. http://www.betttermedicine.com/article/peptic-ulcer-1/symptoms, October 2011.
6. W. A. Hoogerwerf and P. J. Pasricha, Agents Used for Control of Gastric Acidity and Treatment of Peptic Ulcers and Gastro Esophageal Reflux Diseaseedition, pp. 1005–19, McGraw-Hill, New York, NY, USA, 10th edition, 2001.
7. B. J. Marshall and J. R. Warren, “Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration,”The Lancet, vol. 1, no. 8390, pp. 1311–1315, 1984.
8. P. Malfertheiner, F. K. Chan, and K. E. McColl, “Peptic ulcer disease,” The Lancet, 374, 9699, 1449–1461, 2009.
9. Hemant Nagar, Pankaj Tiwari, Deepak Kumar Jain and H.S. Chandel. Evaluation of Anti-ulcer Activity of Stem Bark Extract of AphanmixisPolystachya in Experimental Rats. Ind J Pharm Edu Res, Jul-Sep, 2012/ Vol 46/ Issue 3, 222-227.
10. D. L. Kasper, E. Braunwald, S. L. Hauser, J. L. Jameson, A. S. Fauci, and D. L. Lengo, Principles of Internal Medicine, pp. 221- 222,McGraw-HillMedical Publishing Division, New York, NY, USA, 16th edition, 2005.
11. J. C. Zapata-Colindres, S. Zepeda-G´omez, A.Monta˜no-Loza, E. V´asquez-Ballesteros, J. de Jes´us Villalobos, and F. Valdovinos- Andraca, “The association of Helicobacter pylori infection and nonsteroidal anti-inflammatory drugs in peptic ulcer disease,” Canadian Journal of Gastroenterology, vol. 20, no. 4, pp. 277– 280, 2006.
12. J. Y. Lau, J. Sung, C. Hill, C. Henderson, C.W. Howden, and D. C.Metz, “Systematic review of the epidemiology of complicated peptic ulcer disease: incidence, recurrence, risk factors and mortality,” Digestion, vol. 84, no. 2, pp. 102–113, 2011.
13. R. Kumar, “A review on medicinal plants for peptic ulcer. Scholar Research Library,” Der Pharmacia Lettre, vol. 3, no. 3, pp. 414–420, 2011.
14. G. Patel and S. Jain, “Antiulcer activity of Neriutn indicum in rats,” Research Journal of Pharmacology, vol. 4, no. 3, pp. 66–68, 2010.
15. Osawa, T., 1994. Novel Natural Antioxidants for Utilization in Food and Biological Systems. In: Post Harvest Biochemistry of Plant Food Materials in Tropics, Uritani, L., V.V. Garcia and E.M. Mendoza (Eds.). Japan Scientific Societies Press, Tokyo, Japan, pp: 241-251
16. Khandelwal KR. Practical pharmacognosy techniques and experiments. NiraliPrakashan: India; 2005.
17. Guideline Document on Acute oral Toxicity Testing, Series on Testing and Assessment No. 423. Paris: Organization for Economic Co-Operation and Development, OECD Environment, Health and Safety Publications; 1996. Available from: http//www.oecd.org/ehs.
18. Desai JK, Goyal, RK, Parmar NS. 1997. Review Article Pathogenesis of Peptic ulcer diseases and current trends in therapy. Indian J. Physiology and Pharmacology. vol: 41: 03-15.